Large-scale testing (Phase 3)Study completedNCT00561080
What this trial is testing
Immunogenicity and Safety of a 1-dose Regimen of a Zoster Vaccine Versus Different 2-dose Regimens in Participants ≥ 70 Years of Age. (V211-043)
Who this might be right for
Prevention of : Herpes-Zoster
Merck Sharp & Dohme LLC 759